AU Stock MarketDetailed Quotes

RGT Argent Biopharma Ltd

Watchlist
  • 0.120
  • -0.010-7.69%
20min DelayMarket Closed May 14 10:49 AET
8.66MMarket Cap-0.25P/E (Static)

About Argent Biopharma Ltd Company

Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.

Company Profile

SymbolRGT
Company NameArgent Biopharma Ltd
Founded2005
MarketASX
Employees60
Fiscal Year Ends06-30
Address295 Rokeby Road Suite 1
CitySubiaco
CountryAustralia
Zip Code6008
Phone+61 865552950
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000 1300 850 505

Company Executives

  • Name
  • Position
  • Salary
  • Roby Reuven Zomer
  • Chief Executive Officer,Managing Director
  • --
  • Stephen Barry Parker
  • Non-Executive Director
  • --
  • Ross Grant Thomas Walker
  • Non-Executive Director
  • --
  • Layton Patrick Mills
  • Non-Executive Director
  • --
  • Daniel Robinson
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More